Unless otherwise indicated, this information has been self-reported and has not been
verified by the Board of Medicine.
Academic Appointments
Last Updated 2/12/2024
Uniformed Services University Of The Health Sciences F. Edward Hébert School Of Medicine - Bethesda MD
Rank:
Instructor
Years:
2004-2009
Uniformed Services University Of The Health Sciences F. Edward Hébert School Of Medicine - Bethesda MD
Rank:
Assistant Professor
Years:
2009-Present
Publications
(up to ten in the last five years)
Last Updated 2/12/2024
Activation of Prostate-Specific Antigen Precursor (pro-PSA) by Prostin, a novel Human Prostatic Serine Protease Identified by Degenerate PCR
Biochemistry
40(6): 1679-1687
Date: 02 2001
Temporary-Defferred Therapy (TDT) (Watchful Waiting) in Low Risk Localized Prostate Cancer in Men under age 70 in the PSA Era: Results from the DOD CPDR National Database
Journal of Clinical Oncology
1:21(21): 4001-4008
Date: 11 2003
Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial.
Lancet Oncol. 2015 Feb;16(2):177-86. doi: 10.1016/S1470-2045(14)71181-7. Epub 2015 Jan 13.
Date: 01 2015
www.ncbi.nlm.nih.gov/pubmed/25592632
Molecular profiling and targeted therapy for advanced thoracic malignancies: a biomarker-derived, multiarm, multihistology phase II basket trial.
J Clin Oncol. 2015 Mar 20;33(9):1000-7. doi: 10.1200/JCO.2014.58.2007. Epub 2015 Feb 9.
Date: 03 2015
www.ncbi.nlm.nih.gov/pubmed/25667274
Safety and activity of RRx-001 in patients with advanced cancer: a first-in-human, open-label, dose-escalation phase 1 study.
Lancet Oncol. 2015 Sep;16(9):1133-42. doi: 10.1016/S1470-2045(15)00089-3. Epub 2015 Aug 19.
Date: 09 2015
www.ncbi.nlm.nih.gov/pubmed/26296952
Survival and Racial Differences of Non-Small Cell Lung Cancer in the United States Military.
J Gen Intern Med. 2015 Oct;30(10):1406-12. doi: 10.1007/s11606-015-3280-z. Epub 2015 Mar 25.
Date: 10 2015
www.ncbi.nlm.nih.gov/pubmed/25805503
Selumetinib with and without erlotinib in KRAS mutant and KRAS wild-type advanced nonsmall-cell lung cancer.
Ann Oncol. 2016 Apr;27(4):693-9. doi: 10.1093/annonc/mdw008. Epub 2016 Jan 22.
Date: 01 2016
www.ncbi.nlm.nih.gov/pubmed/26802155